Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 2/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.42 |
| ▸ | MAPK7 | Q13164 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.34 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6424805 | 0.98 | PTGS1 (0.42) | PTGS1PTGS2MAPK7ALDH1A1KMT2A | |
| SCHEMBL6425755 | 0.91 | PTGS2 (0.52) | PTGS1PTGS2MAPK7ALDH1A1KMT2A | |
| SCHEMBL6424347 | 0.89 | MAPK7 (0.35) | MAPK7ALDH1A1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL6424257 | 0.89 | PTGS2 (0.52) | PTGS1PTGS2MAPK7ALDH1A1KMT2A | |
| SCHEMBL6427353 | 0.88 | LMNA (0.32) | ALDH1A1KMT2ASMN1; SMN2MEN1MAPT | |
| SCHEMBL6427087 | 0.88 | NR1H4 (0.36) | MAPK7ALDH1A1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL6426755 | 0.86 | HTR1E (0.33) | KMT2ARAB9ASMN1; SMN2NPC1HPGD | |
| SCHEMBL6423345 | 0.85 | PTGS2 (0.59) | PTGS1PTGS2KMT2ARAB9AMEN1 | |
| SCHEMBL6423732 | 0.85 | PTGS2 (0.47) | PTGS1PTGS2ALDH1A1KMT2ATAS1R3 | |
| SCHEMBL6427391 | 0.84 | PTGS2 (0.45) | PTGS1PTGS2ALDH1A1KMT2ATAS1R3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050234244-A1 | Synthesis of COX-2 and FAAH inhibitors | IRONWOOD PHARMACEUTICALS, INC. | 2005-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050234244-A1 | Synthesis of COX-2 and FAAH inhibitors | FAAH2, FAAH, PTGES2 | PTGS1 7/4885PTGS2 4/4885MAPK7 2506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.